UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways

The Journal of pharmacology and experimental therapeutics, 2003-09, Vol.306 (3), p.954

2003

Volltextzugriff (PDF)

Cell infiltration into a 3D electrospun fiber and hydrogel hybrid scaffold implanted in the brain

Biomatter (Austin, TX), 2015, Vol.5 (1), p.e1005527-e1005527

2015

Volltextzugriff (PDF)

Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways

The Journal of pharmacology and experimental therapeutics, 1995-11, Vol.275 (2), p.899

1995

Volltextzugriff (PDF)

Generalization of serotonin (5-HT) 1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT

Neuropharmacology, 2001-06, Vol.40 (7), p.899-910

2001

Volltextzugriff (PDF)

Biomaterial design considerations for repairing the injured spinal cord

Critical reviews in biomedical engineering, 2011, Vol.39 (2), p.125-180

2011

Volltextzugriff (PDF)

Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297

European journal of pharmacology, 1994-11, Vol.265 (3), p.175-177

1994

Volltextzugriff (PDF)

Blockade of transmission at NMDA receptors facilitates the electrical and synthetic activity of ascending serotoninergic neurones

Brain research, 1994-09, Vol.656 (2), p.427-431

1994

Volltextzugriff (PDF)

S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats

European journal of pharmacology, 1994-08, Vol.260 (2-3), p.R3-R5

1994

Volltextzugriff (PDF)

WAY 100,135 and (-)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo

European journal of pharmacology, 1993-08, Vol.240 (2-3), p.307-310

1993

Volltextzugriff (PDF)

Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells: respective roles of Vav and Bcr-Abl GEFs

Oncogene, 2008-04, Vol.27 (19), p.2673-2685

2008

Volltextzugriff (PDF)

5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat

The Journal of pharmacology and experimental therapeutics, 1993-01, Vol.264 (1), p.95

1993

Volltextzugriff (PDF)

A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194

The Journal of pharmacology and experimental therapeutics, 1998-10, Vol.287 (1), p.187

1998

Volltextzugriff (PDF)

S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride

The Journal of pharmacology and experimental therapeutics, 1998-10, Vol.287 (1), p.167

1998

Volltextzugriff (PDF)

Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra

Brain research, 2001-11, Vol.920 (1-2), p.41-54

2001

Volltextzugriff (PDF)

Intracerebral dopaminergic transplants are not activated by electrical footshock stress activating in situ mesocorticolimbic neurons

Neuroscience letters, 1988-07, Vol.90 (1), p.83-88

1988

Volltextzugriff (PDF)

Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats

Journal of neurochemistry, 1997-12, Vol.69 (6), p.2616-2619

1997

Volltextzugriff (PDF)

Spontaneous and graft-induced behavioral recovery after 6-hydroxydopamine lesion of the nucleus accumbens in the rat

Brain research, 1987-03, Vol.407 (2), p.376-380

1987

Volltextzugriff (PDF)

S 14671 : a novel naphthylpiperazine 5-HT1A agonist of high efficacy and exceptional in vivo potency

European journal of pharmacology, 1991-10, Vol.203 (2), p.319-322

1991

Volltextzugriff (PDF)

Involvement of neuropeptide Y in neuroendocrine stress responses. Central and peripheral studies

Journal of neural transmission. Supplementum, 1990, Vol.29, p.65

1990

Volltextzugriff (PDF)

5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm

The Journal of pharmacology and experimental therapeutics, 1994-04, Vol.269 (1), p.121

1994

Volltextzugriff (PDF)

Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy

The Journal of pharmacology and experimental therapeutics, 1995-11, Vol.275 (2), p.885

1995

Volltextzugriff (PDF)

Multiple alpha-2 adrenergic receptor subtypes. II. Evidence for a role of rat R alpha-2A adrenergic receptors in the control of nociception, motor behavior and hippocampal synthesis of noradrenaline

The Journal of pharmacology and experimental therapeutics, 1994-09, Vol.270 (3), p.958

1994

Volltextzugriff (PDF)

Antagonist properties of LY 165,163 at pre- and postsynaptic dopamine D2, D3 and D1 receptors: modulation of agonist actions at 5-HT1A receptors in vivo

The Journal of pharmacology and experimental therapeutics, 1995-06, Vol.273 (3), p.1418

1995

Volltextzugriff (PDF)

Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924

Naunyn-Schmiedeberg's archives of pharmacology, 2003-09, Vol.368 (3), p.188-199

2003

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(51)

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways

Cell infiltration into a 3D electrospun fiber and hydrogel hybrid scaffold implanted in the brain

Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways

Generalization of serotonin (5-HT) 1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT

Biomaterial design considerations for repairing the injured spinal cord

Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297

Blockade of transmission at NMDA receptors facilitates the electrical and synthetic activity of ascending serotoninergic neurones

S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats

WAY 100,135 and (-)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo

Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells: respective roles of Vav and Bcr-Abl GEFs

5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat

A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194

Similar post-lesion receptor readjustments following the unilateral 6-hydroxydopamine lesion of the dopaminergic mesotelencephalic system in neonatal and adult rats

S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride

Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra

Intracerebral dopaminergic transplants are not activated by electrical footshock stress activating in situ mesocorticolimbic neurons

Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats

Spontaneous and graft-induced behavioral recovery after 6-hydroxydopamine lesion of the nucleus accumbens in the rat

S 14671 : a novel naphthylpiperazine 5-HT1A agonist of high efficacy and exceptional in vivo potency

Involvement of neuropeptide Y in neuroendocrine stress responses. Central and peripheral studies

5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm

Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy

Multiple alpha-2 adrenergic receptor subtypes. II. Evidence for a role of rat R alpha-2A adrenergic receptors in the control of nociception, motor behavior and hippocampal synthesis of noradrenaline

Antagonist properties of LY 165,163 at pre- and postsynaptic dopamine D2, D3 and D1 receptors: modulation of agonist actions at 5-HT1A receptors in vivo

Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924

Aktive Filter

Suchergebnisse filtern